Numinus Wellness Inc. (OTCMKTS:NUMIF – Get Rating) was the recipient of a large decline in short interest during the month of December. As of December 30th, there was short interest totalling 236,600 shares, a decline of 28.8% from the December 15th total of 332,200 shares. Based on an average daily trading volume, of 421,200 shares, the days-to-cover ratio is currently 0.6 days.

Wall Street Analyst Weigh In

Separately, Maxim Group initiated coverage on Numinus Wellness in a research note on Thursday, December 8th. They set a "positive" rating and a $0.50 price target on the stock.

Numinus Wellness Price Performance

Shares of NUMIF stock remained flat at C$0.21 on Friday. The stock had a trading volume of 62,783 shares, compared to its average volume of 124,483. Numinus Wellness has a fifty-two week low of C$0.11 and a fifty-two week high of C$0.65.

About Numinus Wellness

Numinus Wellness Inc provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health. The company operates through three segments: Research Operations, Canadian Clinic Network, and U.S Clinic Network. The Research Operations segment offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics.

Featured Articles

• Get a free copy of the StockNews.com research report on Numinus Wellness (NUMIF)
• MarketBeat Week in Review – 1/16 – 1/20
• Does Old Dominion Show That Trucking Is Hitting The Brakes?
• Nordstrom Puts Fear Of Markdowns Into Retail Sector
• Exxon Mobil Stock: Within Striking Distance Of Buy Point
• High-Dividend-Yielding BHP Sees China Driving '23 Growth

Receive News & Ratings for Numinus Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Numinus Wellness and related companies with MarketBeat.com's FREE daily email newsletter.